Skip to content
2000
Volume 21, Issue 4
  • ISSN: 1573-3947
  • E-ISSN: 1875-6301

Abstract

Introduction

Rectal leiomyosarcoma is a rare malignant mesenchymal tumor accounting for <0.1% of all malignant colorectal neoplasms and carries a grave prognosis.

Case Presentation

A 50-year-old postmenopausal, PL woman presented with complaints of abdominal pain for two months, dark-colored loose stools, 10-15 episodes per day for 2-3 months, and gradual weight loss for 4-5 months. On ultrasonography and MRI of the pelvis, a large irregular lobulated ill-defined solid lesion was seen arising from the right side of the pelvis measuring 14 x 8 x 14 cm. The right ovary was not observed to be separate from the mass. There was omental thickening and peritoneal deposits with ascites. The final impression suggested a right-sided malignant ovarian mass with peritoneal dissemination (ORADS-5) with a differential leiomyosarcoma. Her tumor markers (CA-125; CA19-9, and CEA) were raised. Given the strong dilemma between ovarian malignancy and leiomyosarcoma and the advanced stage of the disease, the patient was planned for an ultrasound-guided biopsy of the lesion. The histopathological report revealed atypical spindle cell proliferation with myoid features with the presence of multiple mitotic figures. The diagnosis of rectal leiomyosarcoma was further confirmed with immunohistochemical tests, which were positive for actin and desmin and negative for CD 117 and S100. The patient was referred to oncosurgeon for further management and was planned for surgical resection followed by chemotherapy with intravenous doxorubicin.

Conclusion

Rectal leiomyosarcoma is commonly misdiagnosed as ovarian malignancy because of its exophytic growth and similar clinical features at the time of the presentation. Hence, clinicians must be aware of these differentials for the successful management of cases.

Loading

Article metrics loading...

/content/journals/cctr/10.2174/0115733947302172240502062032
2024-05-13
2025-09-02
Loading full text...

Full text loading...

References

  1. AggarwalG. SharmaS. ZhengM. Primary leiomyosarcomas of the gastrointestinal tract in the post–gastrointestinal stromal tumor era.Ann. Diagn. Pathol.201216653254010.1016/j.anndiagpath.2012.07.005 22917807
    [Google Scholar]
  2. SeverinoN.P. WaisbergJ. FragosoM.C.B.V. Rectal leiomyosarcoma as the initial phenotypic manifestation of Li–Fraumeni-like syndrome: A case report and review of the literature.J. Med. Case Reports202216146810.1186/s13256‑022‑03671‑6 36529791
    [Google Scholar]
  3. OuhY.T. HongJ.H. MinK.J. SoK.A. LeeJ.K. Leiomyosarcoma of the rectum mimicking primary ovarian carcinoma: A case report.J. Ovarian Res.2013612710.1186/1757‑2215‑6‑27 23587096
    [Google Scholar]
  4. OrucM.T. MayırB. BılecıkT. SakarA. ErinekciA.R. Rectal leiomyosarcoma, late complication of pelvic radiotherapy.Int. J. Colorectal Dis.201530457157210.1007/s00384‑014‑2020‑x 25296708
    [Google Scholar]
  5. BatesD.D.B. de PaulaM.C.F. HorvatN. Beyond adenocarcinoma: MRI of uncommon rectal neoplasms and mimickers.Abdom. Radiol.201944113581359410.1007/s00261‑019‑02045‑9 31069482
    [Google Scholar]
  6. DeviJ. Leiomyosarcoma of rectum mimicking primary ovarian tumour.Annals Pathol Lab Med201852C28C3110.21276/APALM.1561
    [Google Scholar]
  7. IjeriS.K. RathodP.S. KundargiR. Gastrointestinal stromal tumor mimicking as ovarian tumor in gynaecologic oncology.Indian J. Surg. Oncol.201671566110.1007/s13193‑015‑0479‑8 27065683
    [Google Scholar]
  8. ManglaA. YadavU. Leiomyosarcoma.In: StatPearls.Treasure Island, FLStatPearls Publishing2024
    [Google Scholar]
  9. GeorgeS. SerranoC. HensleyM.L. CoquardR.I. Soft tissue and uterine leiomyosarcoma.J. Clin. Oncol.201836214415010.1200/JCO.2017.75.9845 29220301
    [Google Scholar]
  10. AvendanoT.L.M. FloresJ.A.C. Leiomyosarcoma of the rectosigmoid junction, a case report.Radiol. Case Rep.202015101887189010.1016/j.radcr.2020.07.052 32904201
    [Google Scholar]
  11. JiangZ.X. ZhangS.J. PengW.J. YuB.H. Rectal gastrointestinal stromal tumors: Imaging features with clinical and pathological correlation.World J. Gastroenterol.201319203108311610.3748/wjg.v19.i20.3108 23716991
    [Google Scholar]
  12. AnnicchiaricoA. MontaliF. BaldinuM. CasaliL. VirgilioE. CostiR. Leiomyosarcoma of the rectum: A systematic review of recent literature.J. Surg. Oncol.2024129236538010.1002/jso.27481 37814590
    [Google Scholar]
  13. SuhD.S. KimY.H. YunK.Y. An unusual case of pedunculated subserosal leiomyosarcoma of the uterus mimicking ovarian carcinoma.J. Ovarian Res.201691210.1186/s13048‑016‑0212‑4 26857119
    [Google Scholar]
  14. JinJ.S. WuC.S. YehC.H. HuangB.P. TsaoT.Y. Inflammatory fibroid polyp of rectum mimicking rectal cancer.Kaohsiung J. Med. Sci.201329846046310.1016/j.kjms.2012.12.007 23906237
    [Google Scholar]
  15. MaccagnoA. SanderB. DintnerS. HarloffM. FüzesiL. MärklB. Inflammatory fibroid polyp: A series of 29 cases and a systematic review of the literature.Human Patholog Rep20233230070310.1016/j.hpr.2023.300703
    [Google Scholar]
  16. YoonH.J. HyunD.W. HwangS.Y. An unusual case of dedifferentiated leiomyosarcoma of the primary mesentery mimicking ovarian cancer.Int. J. Clin. Exp. Pathol.2019121141504155 31933813
    [Google Scholar]
  17. NassifM.O. HabibR.A. AlmarzoukiL.Z. TrabulsiN.H. Systematic review of anorectal leiomyosarcoma: Current challenges and recent advances.World J. Gastrointest. Surg.201911833434110.4240/wjgs.v11.i8.334 31523383
    [Google Scholar]
  18. GladdyR.A. QinL.X. MoracoN. AgaramN.P. BrennanM.F. SingerS. Predictors of survival and recurrence in primary leiomyosarcoma.Ann. Surg. Oncol.20132061851185710.1245/s10434‑013‑2876‑y 23354568
    [Google Scholar]
  19. SahliN. KhmouM. KhalilJ. Unusual evolution of leiomyosarcoma of the rectum: A case report and review of the literature.J. Med. Case Reports201610124910.1186/s13256‑016‑1047‑8 27633779
    [Google Scholar]
  20. JudsonI. VerweijJ. GelderblomH. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: A randomised controlled phase 3 trial.Lancet Oncol.201415441542310.1016/S1470‑2045(14)70063‑4 24618336
    [Google Scholar]
  21. TapW.D. JonesR.L. Van TineB.A. Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: An open-label phase 1b and randomised phase 2 trial.Lancet20163881004348849710.1016/S0140‑6736(16)30587‑6 27291997
    [Google Scholar]
/content/journals/cctr/10.2174/0115733947302172240502062032
Loading
/content/journals/cctr/10.2174/0115733947302172240502062032
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test